These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 20619511)
1. Synthesis and pharmacological evaluation of new methyloxiranylmethoxyxanthone analogues. Woo S; Kang DH; Nam JM; Lee CS; Ha EM; Lee ES; Kwon Y; Na Y Eur J Med Chem; 2010 Sep; 45(9):4221-8. PubMed ID: 20619511 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of new xanthone analogues and their biological activity test--cytotoxicity, topoisomerase II inhibition, and DNA cross-linking study. Woo S; Jung J; Lee C; Kwon Y; Na Y Bioorg Med Chem Lett; 2007 Mar; 17(5):1163-6. PubMed ID: 17194586 [TBL] [Abstract][Full Text] [Related]
3. New benzoxanthone derivatives as topoisomerase inhibitors and DNA cross-linkers. Cho HJ; Jung MJ; Woo S; Kim J; Lee ES; Kwon Y; Na Y Bioorg Med Chem; 2010 Feb; 18(3):1010-7. PubMed ID: 20093033 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological evaluation, and molecular docking study of 3-(3'-heteroatom substituted-2'-hydroxy-1'-propyloxy) xanthone analogues as novel topoisomerase IIα catalytic inhibitor. Jun KY; Lee EY; Jung MJ; Lee OH; Lee ES; Park Choo HY; Na Y; Kwon Y Eur J Med Chem; 2011 Jun; 46(6):1964-71. PubMed ID: 21419530 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and topoisomerase II inhibitory and cytotoxic activity of oxiranylmethoxy- and thiiranylmethoxy-chalcone derivatives. Na Y; Nam JM Bioorg Med Chem Lett; 2011 Jan; 21(1):211-4. PubMed ID: 21115246 [TBL] [Abstract][Full Text] [Related]
6. 3-(3-Butylamino-2-hydroxy-propoxy)-1-hydroxy-xanthen-9-one acts as a topoisomerase IIα catalytic inhibitor with low DNA damage. Park SE; Chang IH; Jun KY; Lee E; Lee ES; Na Y; Kwon Y Eur J Med Chem; 2013 Nov; 69():139-45. PubMed ID: 24013413 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and pharmacological evaluation of novel bisindolylalkanes analogues. Song YL; Dong YF; Yang T; Zhang CC; Su LM; Huang X; Zhang DN; Yang GL; Liu YX Bioorg Med Chem; 2013 Dec; 21(24):7624-7. PubMed ID: 24262885 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, cytotoxicity and topoisomerase II inhibitory activity of lomefloxacin derivatives. Zhou Y; Xu X; Sun Y; Wang H; Sun H; You Q Bioorg Med Chem Lett; 2013 May; 23(10):2974-8. PubMed ID: 23566520 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of aroylthiourea derivatives of 4-β-amino-4'-O-demethyl-4-desoxypodophyllotoxin as novel topoisomerase II inhibitors. Zhao Y; Ge CW; Wu ZH; Wang CN; Fang JH; Zhu L Eur J Med Chem; 2011 Mar; 46(3):901-6. PubMed ID: 21277655 [TBL] [Abstract][Full Text] [Related]
10. Novel antitumor indolizino[6,7-b]indoles with multiple modes of action: DNA cross-linking and topoisomerase I and II inhibition. Chaniyara R; Tala S; Chen CW; Zang X; Kakadiya R; Lin LF; Chen CH; Chien SI; Chou TC; Tsai TH; Lee TC; Shah A; Su TL J Med Chem; 2013 Feb; 56(4):1544-63. PubMed ID: 23360284 [TBL] [Abstract][Full Text] [Related]
11. Oxiranylmethyloxy or thiiranylmethyloxy-azaxanthones and -acridone analogues as potential topoisomerase I inhibitors. Cho HJ; Jung MJ; Kwon Y; Na Y Bioorg Med Chem Lett; 2009 Dec; 19(23):6766-9. PubMed ID: 19836231 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiproliferative activity of some ellipticine-like 11H-pyrido[a]carbazole derivatives. Ferlin MG; Gia O; Dalla Via L ChemMedChem; 2011 Oct; 6(10):1872-83. PubMed ID: 21826796 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of 4β-carbamoyl epipodophyllotoxins as potential antitumour agents. Kamal A; Kumar BA; Suresh P; Juvekar A; Zingde S Bioorg Med Chem; 2011 May; 19(9):2975-9. PubMed ID: 21489802 [TBL] [Abstract][Full Text] [Related]
16. Antitumor agents. Part 235: Novel 4'-ester etoposide analogues as potent DNA topoisomerase II inhibitors with improved therapeutic potential. Xiao Z; Vance JR; Bastow KF; Brossi A; Wang HK; Lee KH Bioorg Med Chem; 2004 Jun; 12(12):3363-9. PubMed ID: 15158805 [TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of the novel DNA topoisomerase II inhibitors: esterification and amination substituted 4'-demethylepipodophyllotoxin derivates exhibiting anti-tumor activity by activating ATM/ATR signaling pathways. Xiao L; Zhao W; Li HM; Wan DJ; Li DS; Chen T; Tang YJ Eur J Med Chem; 2014 Jun; 80():267-77. PubMed ID: 24793877 [TBL] [Abstract][Full Text] [Related]
18. Novel indolizino[8,7-b]indole hybrids as anti-small cell lung cancer agents: Regioselective modulation of topoisomerase II inhibitory and DNA crosslinking activities. Chang SM; Christian W; Wu MH; Chen TL; Lin YW; Suen CS; Pidugu HB; Detroja D; Shah A; Hwang MJ; Su TL; Lee TC Eur J Med Chem; 2017 Feb; 127():235-249. PubMed ID: 28064078 [TBL] [Abstract][Full Text] [Related]
19. Indeno[1,2-c]isoquinolin-5,11-diones conjugated to amino acids: Synthesis, cytotoxicity, DNA interaction, and topoisomerase II inhibition properties. Ahn G; Lansiaux A; Goossens JF; Bailly C; Baldeyrou B; Schifano-Faux N; Grandclaudon P; Couture A; Ryckebusch A Bioorg Med Chem; 2010 Nov; 18(22):8119-33. PubMed ID: 20961767 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activity of 2,4-di-p-phenolyl-6-2-furanyl-pyridine as a potent topoisomerase II poison. Karki R; Park C; Jun KY; Kadayat TM; Lee ES; Kwon Y Eur J Med Chem; 2015 Jan; 90():360-78. PubMed ID: 25437622 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]